Animal models exist to study intrinsic drug-induced liver injury

Overview Debates Related claims Topics

Generation of reactive metabolites during medication metabolism is a compound-specific risk factor for liver toxicity

Intrinsic drug-induced liver injury is dose-dependent and predictable

Idiosyncratic drug-induced liver injury is unpredictable and generally not related to dose

Clinical worsening, progressive biochemical deterioration, or diagnostic uncertainty warrants referral to a gastroenterologist or hepatologist

Susceptibility to idiosyncratic drug-induced liver injury has a genetic component

Drug-induced liver injury is broadly classified into intrinsic and idiosyncratic forms

The presence of jaundice in suspected drug-induced liver injury is an indication for gastroenterology or hepatology referral

Epidemiological data estimates the incidence of idiosyncratic drug-induced liver injury at approximately 20 cases per 100,000 person-years

Practice guidelines recommend a routine right upper quadrant ultrasound during the evaluation of suspected drug-induced liver injury

Hepatic metabolism of a compound by cytochrome P450 enzymes is a risk factor for liver injury

Drug-induced liver injury is categorized as hepatocellular when AST and ALT elevations predominate, or cholestatic when alkaline phosphatase elevation predominates

Serum bilirubin elevation, rather than the absolute level of aminotransferases, is the primary determinant of severe outcomes in drug-induced liver injury

Severe drug-induced liver injury can cause symptoms including right upper quadrant pain, pruritus, fatigue, nausea, and vomiting

Patients with drug-induced liver injury and severe jaundice require liver biochemistry monitoring every two to three days

Patients with underlying liver disease face a three- to four-fold higher risk of poor outcomes from drug-induced liver injury compared to patients without liver disease

Cirrhosis confers a higher risk of adverse outcomes from drug-induced liver injury than chronic hepatitis

Idiosyncratic drug-induced liver injury is a diagnosis of exclusion without a definitive gold-standard test

In an MIT weight-editing study led by Rukia Takahi, GPT-6 Astra modified 0.016% of the weights in Qwen-350-8B, yielding a sixfold increase on math benchmarks and a threefold increase in instruction following

In a 2026 Demos study, artificial intelligence models repeated or endorsed false claims from the Foundation for Battle and Justice (R-FBI) alleging the Ukrainian government processes dead soldiers into meat products 16% of the time

An MIT research team led by PhD student Rukia Takahi found that GPT-6 Astra can directly read and modify neural network weights of a smaller model to improve performance